ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 Z17.421

Billable / Specific

Hormone receptor negative with human epidermal growth factor receptor 2 negative status

Z17
Block
3
Synonyms
0
LCDs
0
Payer Policies
0
Linked CPTs

About ICD-10-CM Z17.421

ICD-10-CM code Z17.421 represents Hormone receptor negative with human epidermal growth factor receptor 2 negative status. This is a billable/specific code in the Factors Influencing Health Status chapter (block Z17). The 2026 edition of ICD-10-CM Z17.421 became effective on October 1, 2025.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under Z17.421. Per CMS ICD-10-CM Tabular 2026.

  • HR- with HER2-
  • TNBC
  • Triple negative breast cancer

Medicare LCD Coverage for Z17.421

Local Coverage Determinations (LCDs) from CMS MACs that list Z17.421 as a covered diagnosis.

No Medicare LCDs reference Z17.421 as covered

This doesn't mean the code isn't covered, it means no MAC has issued a Local Coverage Determination naming this specific code. Coverage may still apply under National Coverage Determinations or general medical-necessity rules.

Commercial Payer Coverage

Coverage policies from major commercial payers referencing Z17.421.

No commercial payer policies reference Z17.421 on file

Our payer policy database covers Aetna, Cigna, Anthem, BCBS, Humana, and Medicare Advantage plans, but Z17.421 doesn't currently appear in any indexed policy. The code may still be covered under standard plan benefits.

CPT Codes Commonly Billed with Z17.421

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

No procedure linkages on file for Z17.421

We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.

ICD-10 Z17.421, Billing FAQ

Is ICD-10 code Z17.421 billable? +

Yes, Z17.421 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to Z17.421? +

ICD-10 Z17.421 includes: HR- with HER2-; TNBC; Triple negative breast cancer.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on May 31, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included